Characterization of the typical multidrug resistance profile in human uveal melanoma cell lines and in mouse liver metastasis derivatives

Melanoma Research

Volumn 15, Issue 4, 2005, Pages 257-266

  Labialle, Stéphane ^a   Dayan, Guila ^b   Gambrelle, Joël ^b,c   Gayet, Landry ^b   Barakat, Stéphane ^b   Devouassoux Shisheboran, Mojgan ^c   Bernaud, Jeanine ^d   Rigal, Dominique ^d   Grange, Jean Daniel ^c   Baggetto, Loris G ^b,e  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

^c CROIX ROUSSE HOSPITAL   (France)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

^e INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

Author keywords

LRP MVP; Metastasis; MRP1; Multidrug resistance; P glycoprotein; Skin melanoma; Uveal melanoma

Indexed keywords

DAUNORUBICIN; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER METASTASIS; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UVEA MELANOMA;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MELANOMA; MICE; MICE, INBRED C57BL; MICE, NUDE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; P-GLYCOPROTEINS; SKIN NEOPLASMS; UVEAL NEOPLASMS; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 23744486994     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200508000-00005     Document Type: Article

References (28)

1. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 1988; 32:239-251.
2. Cree IA. Cell cycle and melanoma - two different tumours from the same cell type. J Pathol 2000; 191:112-114.
3. Kath R, Hayungs J, Bornfeld N, Sauerwein W, Hoffken K, Seeber S. Prognosis and treatment of disseminated uveal melanoma. Cancer 1993; 72:2219-2223.
4. Chu E, De Vita VT Jr. Principles of chemotherapy. In: De Vita VT Jr, Hellman S, Rosenberg SA (editors): Principles and practice of oncology. Philadelphia, PA: J.B. Lippincott; 1989, pp. 276-300.
5. McNamara M, Clynes M, Dunne B, NicAmhlaoibh R, Lee WR, Barnes C, et al. Multidrug resistance in ocular melanoma. Br J Ophthalmol 1996; 80:1009-1012.
6. Satherley K, de Souza L, Neale MH, Alexander RA, Myatt N, Foss AJ, et al. Relationship between expression of topoisomerase II isoforms and chemosensitivity in choroidal melanoma. J Pathol 2000; 192:174-181.
7. Baggetto LG. Biochemical, genetic, and metabolic adaptations of tumor cells that express the typical multidrug-resistance phenotype. Reversion by new therapies. J Bioenerg Biomembr 1997; 29:401-413.
8. Ueda K, Cornwell MM, Gottesman MM, Pastan I, Roninson IB, Ling V, et al. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun 1986; 141:956-962.
9. Kane SE, Pastan I, Gottesman MM. Genetic basis of multidrug resistance of tumor cells. J Bioenerg Biomembr 1990; 22:593-618.
10. Walker JE, Saraste M, Runswick MJ, Gay NJ. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J 1982; 1:945-951.
11. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258:1650-1654.
12. Zaman GJ, Flens MJ, van Leusden MR, de Haas M, Mulder HS, Lankelma J, et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 1994; 91:8822-8826.
13. Hipfner DR, Gauldie SD, Deeley RG, Cole SP. Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res 1994; 54:5788-5792.
14. Scheffer GL, Wijngaard PL, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, et al. The drug resistance-related protein LRP is the human major vault protein. Nat Med 1995; 1:578-582.
15. Slovak ML, Ho JP, Cole SP, Deeley RG, Greenberger L, de Vries EG, et al. The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification. Cancer Res 1995; 55:4214-4219.
16. Schadendorf D, Makki A, Stahr C, van Dyck A, Wanner R, Scheffer GL, et al. Membrane transport proteins associated with drug resistance expressed in human melanoma. Am J Pathol 1995; 147:1545-1552.
17. Izquierdo MA, Scheffer GL, Flens MJ, Giaccone G, Broxterman HJ, Meijer CJ, et al. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am J Pathol 1996; 148:877-887.
18. Mossink MH, van Zon A, Scheper RJ, Sonneveld P, Wiemer EA. Vaults: a ribonucleoprotein particle involved in drug resistance?. Oncogene 2003; 22:7458-7467.
19. De Waard-Siebinga I, Blom DJ, Griffioen M, Schrier PI, Hoogendoorn E, Beverstock G, et al. Establishment and characterization of a uveal-melanoma cell line. Int J Cancer 1995; 62:155-161.
20. Luyten GP, Naus NC, Mooy CM, Hagemeijer A, Kan-Mitchell J, Van Drunen E, et al. Establishment and characterization of primary and metastatic uveal melanoma cell lines. Int J Cancer 1996; 66:380-387.
21. Gambrelle J, Dayan G, Baggetto LG, Devouassoux Shisheboran M, Salle M, Labialle S, et al. Uveal melanoma in an 18 year old African black male. Acta Ophthalmol Scand 2004; 83:134-136.
22. Baggetto LG, Dong M, Bernaud J, Espinosa L, Rigal D, Bonvallet R, et al. In vitro and in vivo reversal of cancer cell multidrug resistance by the semi-synthetic antibiotic tiamulin. Biochem Pharmacol 1998; 56:1219-1228.
23. Donoso LA, Berd D, Augsburger JJ, Mastrangelo MJ, Shields JA. Metastatic uveal melanoma. Pretherapy serum liver enzyme and liver scan abnormalities. Arch Ophthalmol 1985; 103:796-798.
24. Donoso LA, Nagy RM, McFall RC, Edelberg KE, Vossler DG. Metastatic choroidal melanoma. Hepatic binding protein reactivity toward a liver-metastasizing clone. Arch Ophthalmol 1983; 101:787-790.
25. van der Pol JP, Blom DJ, Flens MJ, Luyten GP, de Waard-Siebinga I, Koornneef L, et al. Multidrug resistance-related proteins in primary choroidal melanomas and in vitro cell lines. Invest Ophthalmol Vis Sci 1997; 38:2523-2530.
26. Chevillard S, Vielh P, Vallidire P, Robert J, Marie JP. [A study of the expression of MDR1 gene in solid tumors. Initial results of a multicenter evaluation]. Bull Cancer 1996; 83:626-633.
27. Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene 2003; 22:3138-3151.
28. Rockmann H, Schadendorf D. Drug resistance in human melanoma: mechanisms and therapeutic opportunities. Onkologie 2003; 26:581-587.